Related references
Note: Only part of the references are listed.Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model
E. Decamp et al.
BRAIN RESEARCH (2009)
Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model
Quentin Barraud et al.
EXPERIMENTAL NEUROLOGY (2009)
Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant α-Synuclein
Xiao-Hong Lu et al.
JOURNAL OF NEUROSCIENCE (2009)
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
Maria C. Rodriguez-Oroz et al.
LANCET NEUROLOGY (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism
T. Chaumette et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?
Marie-Francoise Chesselet
EXPERIMENTAL NEUROLOGY (2008)
HsP104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease
Christophe Lo Bianco et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Molecular mechanisms of L-DOPA-induced dyskinesia
Peter Jenner
NATURE REVIEWS NEUROSCIENCE (2008)
A Drosophila model for LRRK2-linked parkinsonism
Zhaohui Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A microRNA feedback circuit in midbrain dopamine neurons
Jongpil Kim et al.
SCIENCE (2007)
Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities
Cheng Wang et al.
JOURNAL OF NEUROSCIENCE (2007)
Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice
Tohru Kitada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila
Sung Bae Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine
Tzu-Kang Sang et al.
JOURNAL OF NEUROSCIENCE (2007)
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
Mats I. Ekstrand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused inactivation of Drosophila Pink1 is rescued by by Parkin
Yufeng Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Jeehye Park et al.
NATURE (2006)
α-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
MG Purisai et al.
NEUROBIOLOGY OF DISEASE (2005)
Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction
J Park et al.
GENE (2005)
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling
YF Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice
LN Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Parkinson-like syndrome induced by continuous MPTP infusion:: Convergent roles of the ubiquitin-proteasome system and α-synuclein
F Fornai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1
MS Goldberg et al.
NEURON (2005)
Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates
E Decamp et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α-synuclein rat model of Parkinson's disease
C Lo Bianco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease
C Lo Bianco et al.
NEUROBIOLOGY OF DISEASE (2004)
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function
M Lundblad et al.
NEUROBIOLOGY OF DISEASE (2004)
Alpha-synuclein and transgenic mouse models
PO Fernagut et al.
NEUROBIOLOGY OF DISEASE (2004)
Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons
MS Goldberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Intranigral infusion of interleukin-1β activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity
J Saura et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein:: A new primate model of Parkinson's disease
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
C Lo Bianco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat
AL McCormack et al.
NEUROBIOLOGY OF DISEASE (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model
LM Björklund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease
PK Auluck et al.
SCIENCE (2002)
From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control
T Boraud et al.
PROGRESS IN NEUROBIOLOGY (2002)
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease
K Abe et al.
BRAIN RESEARCH BULLETIN (2001)
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
E Bezard et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?
M Thiruchelvam et al.
BRAIN RESEARCH (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain
L Antkiewicz-Michaluk et al.
NEUROSCIENCE (2000)